11.72 USD
+0.8 (+7.33%)
ChartMill assigns a Buy % Consensus number of 80% to NVCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 25.18. This target is 114.86% above the current price.
NVCR was analyzed by 14 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NVCR.
In the previous month the buy percentage consensus was at a similar level.
NVCR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-25 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-07-08 | Ladenburg Thalmann | Initiate | Buy |
| 2025-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-04-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-16 | Wedbush | Maintains | Neutral -> Neutral |
| 2025-04-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-02 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-16 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2024-10-01 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-07-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-07-26 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-07-02 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-04-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-04-03 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-03-19 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-03-12 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-02-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-02-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-29 | Wells Fargo | Maintains | Overweight -> Overweight |
NOVOCURE LTD / NVCR FAQ
Can you provide the average price target for NOVOCURE LTD stock?
14 analysts have analysed NVCR and the average price target is 25.18 USD. This implies a price increase of 114.86% is expected in the next year compared to the current price of 11.72.
Can you provide the consensus rating for NOVOCURE LTD stock?
The consensus rating for NOVOCURE LTD (NVCR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NOVOCURE LTD (NVCR)?
The number of analysts covering NOVOCURE LTD (NVCR) is 14.